CHA
CLX icon

Carmichael Hill & Associates’s Clorox CLX Stock Holding History

Carmichael Hill & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$96.3K Sell
591
-11
-2% -$1.63K 0.03% 265
2024
Q2 		$82.2K Sell
602
-95
-14% -$13.2K 0.03% 268
2024
Q1 		$107K Buy
697
+1
+0.1% +$149 0.04% 243
2023
Q4 		$99.3K Sell
696
-234
-25% -$31.2K 0.04% 250
2023
Q3 		$122K Buy
930
+1
+0.1% +$152 0.06% 221
2023
Q2 		$148K Hold
929
– – 0.07% 205
2023
Q1 		$147K Buy
929
+1
+0.1% +$150 0.07% 195
2022
Q4 		$130K Sell
928
-200
-18% -$28.4K 0.07% 207
2022
Q3 		$145K Buy
1,128
+1
+0.1% +$144 0.08% 187
2022
Q2 		$159K Hold
1,127
– – 0.08% 183
2022
Q1 		$157K Buy
1,127
+1
+0.1% +$153 0.07% 199
2021
Q4 		$196K Sell
1,126
-31
-3% -$5.17K 0.09% 180
2021
Q3 		$192K Buy
1,157
+1
+0.1% +$172 0.1% 171
2021
Q2 		$208K Hold
1,156
– – 0.11% 163
2021
Q1 		$223K Sell
1,156
-38
-3% -$7.32K 0.12% 147
2020
Q4 		$241K Buy
1,194
+1
+0.1% +$207 0.14% 129
2020
Q3 		$251K Sell
1,193
-82
-6% -$18.3K 0.17% 113
2020
Q2 		$280K Hold
1,275
– – 0.21% 100
2020
Q1 		$221K Buy
1,275
+1
+0.1% +$165 0.19% 101
2019
Q4 		$196K Buy
+1,274
New +$190K 0.14% 134
2019
Q2 		– Sell
-1,357
Closed -$218K – 111
2019
Q1 		$218K Hold
1,357
– – 0.23% 100
2018
Q4 		$209K Sell
1,357
-150
-10% -$23.4K 0.24% 98
2018
Q3 		$227K Buy
1,507
+1
+0.1% +$142 0.22% 105
2018
Q2 		$204K Sell
1,506
-150
-9% -$18.5K 0.22% 109
2018
Q1 		$220K Sell
1,656
-199
-11% -$26.7K 0.24% 104
2017
Q4 		$276K Buy
+1,855
New +$252K 0.3% 83

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Carmichael Hill & Associates's CLX Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its Clorox (CLX) stake by 1.8% in Q3 2024, selling an estimated $1.63K and leaving 591 shares worth $96.3K. The position accounts for 0.03% of the portfolio, ranked #265.

Carmichael Hill & Associates first reported a position in CLX in Q4 2017 and has held it in 26 quarters since. The position peaked at $280K in Q2 2020. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Carmichael Hill & Associates held 591 shares of Clorox worth $96.3K as of Q3 2024.
  • Carmichael Hill & Associates sold 11 Clorox shares in Q3 2024, an estimated $1.63K.
  • Clorox made up 0.03% of Carmichael Hill & Associates's portfolio in Q3 2024, its #265 holding.
  • Carmichael Hill & Associates first reported a position in Clorox in Q4 2017 and has held it in 26 quarters since.
  • Carmichael Hill & Associates's Clorox position peaked at $280K in Q2 2020.
  • 1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.